Open AccessDecision Points in the Management of Patients with Diabetic Kidney Disease
Author(s) -
Matthew R. Weir
Publication year - 2021
Publication title -
the journal of family practice
Language(s) - English
Resource type - Journals
eISSN - 1533-7294
DOI - 10.12788/jfp.0217
Subject(s) - medicine , kidney disease , mineralocorticoid receptor , disease , diabetes mellitus , nonsteroidal , type 2 diabetes , kidney , intensive care medicine , disease management , endocrinology , aldosterone , parkinson's disease
At the end of the activity, participants will be able to:• Identify the risks of kidney disease and their consequences in patients with type 2 diabetes (T2D).• Appropriately screen for the presence of chronic kidney disease (CKD) in patients with T2D.• Initiate evidence-based therapy to slow the progression of kidney disease in patients with T2D and CKD.• Describe the benefits and limitations of the steroidal and nonsteroidal mineralocorticoid receptor antagonists in the treatment of patients with DKD